Amylyx Pharmaceuticals, Inc.AMLXNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-167.80M
↓ 118% below average
Average (5y)
$-77.03M
Historical baseline
Range
High:$10.68M
Low:$-182.40M
CAGR
+73.5%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-167.80M | -1671.5% |
| 2023 | $10.68M | +105.9% |
| 2022 | $-182.40M | -142.7% |
| 2021 | $-75.15M | -104.0% |
| 2020 | $-36.85M | -244.8% |
| 2019 | $-10.69M | - |